TARGET AUDIENCE
This activity is intended for neurologists, physical therapists and physiatrists, cardiologists, gastroenterologists, ophthalmologists, and respiratory specialists who are practicing in the United States, Europe, and Japan.

PROGRAM OVERVIEW
Discover a dynamic, interactive activity designed to put you in control of your learning journey. Dive into engaging online content that lets you explore non-linearly, guided by your interests and educational needs. Challenge yourself with knowledge-based questions, immerse yourself in real-world case vignettes, and boost your confidence through tailored assessments—all while tracking your progress and outcomes.

Experts focus on myotonic dystrophy type 1 (DM1), including its underlying causes and mechanism of disease, overall prevalence, impact on patients’ lives, its multisystem symptoms, varied pace of progression, and the necessary coordination among a multi-specialty care team to improve diagnosis and ongoing patient management.

Upon completion of this activity, the learners should be able to:

• Summarize the mechanism of disease, prevalence, and overall burden for patients with DM1
• Recognize the broad spectrum of multisystem symptoms and variable progression of DM1 to improve early and accurate diagnosis
• Determine how a multi-specialty care team can improve diagnosis and the ongoing management of patients with DM1

FACULTY
Guillaume Bassez, MD, PhD
Associate Professor of Neurology
Repeat Expansions Research Group
Head of Translational Myotonic Dystrophy Research Group
Institute of Myology
Paris, France

Cynthia Gagnon, PhD
Professor at Sherbrooke University
Scientific Director of the Interdisciplinary Research Group on Neuromuscular Diseases
Faculty of Medicine and Health Sciences
Quebec, Canada

Nicholas Johnson, MD, MSc, FAAN
Professor of Neurology
George Bliley Research Chair in Neurology
Vice-Chair for Research
Director, Center for Inherited Muscle Research (CIMR)
Virginia Commonwealth University
Richmond, VA

Elise Duchesne, pht, PhD
Full Professor
Faculty of Medicine
School of Rehabilitation Sciences
Laval University
Quebec, Canada

PLANNING COMMITTEE
Guillaume Bassez, MD, PhD
Associate Professor of Neurology
Repeat Expansions Research Group
Head of Translational Myotonic Dystrophy Research Group
Institute of Myology
Paris, France

Cynthia Gagnon, PhD
Professor at Sherbrooke University
Scientific Director of the Interdisciplinary Research Group on Neuromuscular Diseases
Faculty of Medicine and Health Sciences
Quebec, Canada

Nicholas Johnson, MD, MSc, FAAN
Professor of Neurology
George Bliley Research Chair in Neurology
Vice-Chair for Research
Director, Center for Inherited Muscle Research (CIMR)
Virginia Commonwealth University
Richmond, VA

In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

Physicians: The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other health care professionals completing this course will be issued a statement of participation.

DISCLOSURE POLICY
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion.

Faculty in this activity may discuss information about pharmaceutical agents that are outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

This activity is supported by an independent medical educational grant from Dyne Therapeutics.

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter assumes no liability for the information herein

Copyright © 2024 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

• The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
• Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein, without The France Foundation's prior written permission

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed at www.francefoundation.com/privacy.